Simon Tam - EndoChoice Holdings Insider

GI -- USA Stock  

USD 8.00  8.00  9,223,372,036,855%

President CEO, Director

Mr. Simon Tam is President, Chief Executive Officer, Director of Gem International Resources Inc. He was a businessman since 1986 and is President of Elite Vantage Development Ltd., a management consulting company since 2004
  CEO Since 2010      
Tam is a Director of DGS Minerals Inc. since September 2007 and President since January 2008; President, CEO and Director of United Coal Holdings Limited since May 2006; Director of EEnergy Ventures Inc. since May 2005 and President since April 2006; Director of Kenieba Goldfields Ltd. since August 2006; President, CEO and Director of Quanta Resources Inc. since February 2009; President and Director of North American Potash Developments Inc. since November 2008; Director of Rochester Resources Ltd. since April 2009; Director of Xemplar Energy Corporationrationration from August 2006 to April 2013 and CEO from June 2008 to April 2013; and President and Director of Xenex Minerals Ltd. since June 2007.

Management Efficiency

The company has Return on Asset (ROA) of (0.47) % which means that for every 100 dollars spent on asset it generated loss of $0.47. This is way below average.
The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7 which is normal for its line of buisiness. EndoChoice Holdings has Current Ratio of 5.52 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Entity Summary

EndoChoice Holdings, Inc., a medical device company, designs and commercializes various solutions for gastrointestinal caregivers in the United States and internationally. EndoChoice Holdings (GI) is traded on New York Stock Exchange in USA. It is located in GEORGIA, U.S.A and employs 501 people. EndoChoice Holdings is listed under Medical Equipment category by Fama And French industry classification.

EndoChoice Holdings Leadership Team

Simon MA, CFO
Scott Huennekens, Chairman, MBA
David Kaufman, Director, MBA
David Mowry, Director
Douglas Ladd, Executive
Rurik Vandevenne, Director
Simon Tam, CEO
John Smyth, Director
James Balkcom, Director
Kevin Rubey, COO, MBA
Mark Gilreath, CEO
Scott Davis, Director
Uri Geiger, Director
Scott Carter, Director
David Gill, CFO
Craig Walker, Director
William Enquist, Director
Michael Ballanger, Director
John Barr, Chairman
Eric Schjelderup, Director

Stock Performance Indicators

Current Sentiment - GI

EndoChoice Holdings Investor Sentiment
Macroaxis portfolio users are indifferent in their judgment towards investing in EndoChoice Holdings. What is your opinion about investing in EndoChoice Holdings? Are you bullish or bearish?
50% Bullish
50% Bearish

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.